UNSPSC 85703516: Revision of nonautologous tissue substitute in right tibia, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in right tibia, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QWG3KZ

UNSPSC 85703516 Revision of nonautologous tissue substitute in right tibia, percutaneous approach is a Commodity code that shows little relevant recent activity under its nominal medical procedure scope. The recent opportunities tagged to this code reflect state and local procurement of occupational health services, disability benefit evaluation, public employee health plan carve-outs, pharmacy benefit management, and temporary clinical staffing — none of which align with orthopedic tissue revision procedures. The code's nominal scope targets surgical implant and tissue-substitution work; the live solicitations do not represent procurement of such services and instead track generalized health services contracting by public jurisdictions.

The issuing bodies include city retirement boards (Phoenix), municipal human resources and benefits departments (Long Beach, Collier County), state transportation agencies (Washington State Department of Transportation), county health systems (Santa Clara, Harris County), and state ferries operations. Geographic activity spans Arizona, California, Florida, and Washington. The most concrete recent example is the Washington State Department of Transportation's RFP 20260825 for occupational medical surveillance services across 14 ferry system locations, with proposals due October 9, 2026 and evaluation weighted 40 percent cost and 60 percent non-cost capability factors. Because the tagged opportunities do not procurement tissue substitutes, revision procedures, or orthopedic implants, the code does not present a meaningful market signal for firms pursuing medical device or surgical procedure work at the state and local level.